This is a very well written application that proposes to investigate the relationship between ApoE and AD. Although initial work suggested that the increased risk for AD seen in patients with the apoE4 polymorphism might arise because apo E4 enhances the rate of Abeta aggregation, this work appeared to be flawed because the apoE studied was lipid-free, which does not represent the normal physiological state of the protein. Subsequent work by the investigators and her colleagues suggested that the opposite was actually the case, i.e., that apoE3 and E2 bind better to Abeta than apoE4. This suggests that some other mechanism may account for the increased risk of AD seen in patients with the apoE4 polymorphism. The investigator has now developed a neuronal toxicity assay for Abeta, that she will use in many of the studies in this application. This proposal is designed to test the following hypothesis: that the protection from Abeta-induced neurotoxicity afforded by apoE3 may result from clearance of the peptide via formation of a stable apoE3:Abeta complex and its uptake by apoE receptors. This hypothesis will be investigated via three aims focusing on: (1) the apoE receptors important for attenuating Abeta toxicity, (2) whether apoE/Abeta complexes stimulate or reduce toxicity, and (3) uptake of Abeta in apoE/Abeta complexes.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG019121-01
Application #
2839664
Study Section
Special Emphasis Panel (ZRG1-MDCN-2 (01))
Program Officer
Snyder, D Stephen
Project Start
2000-06-01
Project End
2005-05-31
Budget Start
2000-06-01
Budget End
2001-05-31
Support Year
1
Fiscal Year
2000
Total Cost
$197,039
Indirect Cost
Name
Evanston Northwestern Healthcare Research Ins
Department
Type
DUNS #
City
Evanston
State
IL
Country
United States
Zip Code
60201
Reed, Miranda N; Hofmeister, Jacki J; Jungbauer, Lisa et al. (2011) Cognitive effects of cell-derived and synthetically derived A? oligomers. Neurobiol Aging 32:1784-94
Stine, W Blaine; Jungbauer, Lisa; Yu, Chunjiang et al. (2011) Preparing synthetic Aýý in different aggregation states. Methods Mol Biol 670:13-32
Fuentealba, Rodrigo A; Liu, Qiang; Zhang, Juan et al. (2010) Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking. PLoS One 5:e11884
Jungbauer, L M; Yu, C; Laxton, K J et al. (2009) Preparation of fluorescently-labeled amyloid-beta peptide assemblies: the effect of fluorophore conjugation on structure and function. J Mol Recognit 22:403-13
Ji, Hong; Zheng, Wei; Falconetti, Celine et al. (2007) 17beta-estradiol deficiency reduces potassium excretion in an angiotensin type 1 receptor-dependent manner. Am J Physiol Heart Circ Physiol 293:H17-22
Manelli, Arlene M; Bulfinch, Lindsey C; Sullivan, Patrick M et al. (2007) Abeta42 neurotoxicity in primary co-cultures: effect of apoE isoform and Abeta conformation. Neurobiol Aging 28:1139-47
LaDu, Mary Jo; Stine Jr, W Blaine; Narita, Masaaki et al. (2006) Self-assembly of HEK cell-secreted ApoE particles resembles ApoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein. Biochemistry 45:381-90
Yun, Sung Hwan; Gamkrelidze, Georgi; Stine, W Blaine et al. (2006) Amyloid-beta1-42 reduces neuronal excitability in mouse dentate gyrus. Neurosci Lett 403:162-5
White, Jill A; Manelli, Arlene M; Holmberg, Kristina H et al. (2005) Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation. Neurobiol Dis 18:459-65
Trommer, Barbara L; Shah, Chirag; Yun, Sung Hwan et al. (2004) ApoE isoform affects LTP in human targeted replacement mice. Neuroreport 15:2655-8

Showing the most recent 10 out of 15 publications